Biodesix Biodesix, Datavant Join in Lung Cancer Data Partnership Datavant will anonymize lung cancer records from the Biodesix biobank and add real-world data to aid researchers and biopharma companies. Biodesix Q1 Revenues Soar on COVID-19 Testing For the three months ended March 31, the firm reported revenues of $28.9 million, compared to $5.1 million in the same period a year ago. Biodesix's Proteomic Method for Predicting Immunotherapy Response Advancing Toward Market Premium The firm will commercialize its Primary Immune Response assay as a laboratory-developed test to help guide immunotherapy decisions in lung cancer patients. Biodesix Secures $30M Term Loan The firm used the proceeds to repay outstanding borrowings of $25.9 million under its existing loan with Innovatus Life Sciences Lending Fund. Biodesix Q4 Revenues More Than Triple on COVID-19 Testing For the three months ended Dec. 31, the Boulder, Colorado-based firm reported revenues of $27.0 million compared to $8.3 million in 2019. Jan 8, 2021 Biodesix Preliminary Q4 Revenues Up Over 200 Percent Dec 11, 2020 Biodesix Q3 Revenues Rise Sharply Nov 23, 2020 Three Investment Banks Initiate Coverage of Biodesix Oct 28, 2020 Biodesix Prices $72M IPO Oct 1, 2020 Quidel Releases Preliminary Q3 Results, Partners with Biodesix for Big Ten Surveillance Aug 17, 2020 Biodesix Turns to Digital PCR to Maintain Round-The-Clock COVID Testing Premium Mar 20, 2020 Biodesix, Bio-Rad Partner on Coronavirus Test Jan 29, 2020 Biodesix, Streck Partner on Cancer CDx Sample Collection Nov 8, 2019 People in the News: Roland Diggelmann, Victor Esch, Scott Hutton, David Brunel, More Jul 29, 2019 Biodesix, Immodulon Collaborating on Pancreatic Cancer Biomarkers Jul 9, 2019 Biodesix to Develop Blood-Based Lung Cancer Diagnostic Using Thermo Sequencing Panel Jan 28, 2019 Biodesix, MRM Proteomics Partner on Lung Cancer Assays Jul 10, 2018 Biodesix Buy Provides Commercial Path Forward for Indi XL2 Lung Nodule Test Premium Jul 9, 2018 Biodesix Acquires Integrated Diagnostics Mar 5, 2018 Biodesix Inks $23M Debt Refinancing Jan 31, 2018 Biodesix, University of Colorado Partner on Lung Cancer Assay Dec 14, 2017 Biodesix Putting Focus on Veristrat's Prognostic Capabilities Premium Nov 17, 2017 Biodesix Pushes Back Immunotherapy Test Development Timeline Premium Jun 20, 2017 Biodesix Receives NY State Approval for GeneStrat Test Jun 12, 2017 Biodesix, Positive Bioscience Ink Distribution Deal for India Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.